StockData
Lyell Immunopharma, Inc. logo

Lyell Immunopharma, Inc. (LYEL) stock

LYELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$13.67−0.98 (-6.69%)

Close on Nov 17, 2026Market cap $334.98MP/E –Yield –

Lyell Immunopharma gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Lyell Immunopharma

Lyell Immunopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Lyell Immunopharma figures

See a number that looks wrong?